AGREEMENT TO PROVIDE ADDITIONAL CAPITALAgreement to Provide Additional Capital • March 1st, 2005 • Arrowhead Research Corp • Services-commercial physical & biological research • Delaware
THIS AGREEMENT TO PROVIDE ADDITIONAL CAPITAL (this “Agreement”) is made and entered into as of February 22, 2005, by and between ARROWHEAD RESEARCH CORPORATION, a Delaware corporation (“Arrowhead”), and CALANDO PHARMACEUTICALS INC., a Delaware corporation (the “Company”).
AMENDMENT NO. 1 TO AGREEMENT TO PROVIDE ADDITIONAL CAPITALAgreement to Provide Additional Capital • March 11th, 2005 • Arrowhead Research Corp • Services-commercial physical & biological research
This Amendment No. 1 to Agreement to Provide Additional Capital (this “Amendment”) is entered into this 9th day of March, 2005, by and between Arrowhead Research Corporation, a Delaware corporation (“Arrowhead”) and Nanotechnica, Inc., a California corporation (the “Company”).
AGREEMENT TO PROVIDE ADDITIONAL CAPITALAgreement to Provide Additional Capital • April 6th, 2006 • Arrowhead Research Corp • Services-commercial physical & biological research • Delaware
THIS AGREEMENT TO PROVIDE ADDITIONAL CAPITAL (this “Agreement”) is made and entered into as of March 31, 2006, by and between ARROWHEAD RESEARCH CORPORATION, a Delaware corporation (“Arrowhead”), and CALANDO PHARMACEUTICALS INC., a Delaware corporation (the “Company”).
AGREEMENT TO PROVIDE ADDITIONAL CAPITALAgreement to Provide Additional Capital • June 16th, 2006 • Arrowhead Research Corp • Services-commercial physical & biological research • Delaware
THIS AGREEMENT TO PROVIDE ADDITIONAL CAPITAL (this “Agreement”) is made and entered into as of June 13, 2006, by and between ARROWHEAD RESEARCH CORPORATION, a Delaware corporation (“Arrowhead”), and NANOPOLARIS, INC., a Delaware corporation (the “Company”).
AGREEMENT TO PROVIDE ADDITIONAL CAPITALAgreement to Provide Additional Capital • December 16th, 2004 • Arrowhead Research Corp • Services-commercial physical & biological research • California
THIS AGREEMENT TO PROVIDE ADDITIONAL CAPITAL (this “Agreement”) is made and entered into as of September 10 , 2004, by and between ARROWHEAD RESEARCH CORPORATION, a Delaware corporation (“Arrowhead”), and NANOTECHNICA, INC., a California corporation (the “Company”).
AMENDMENT NO. 1 TO AGREEMENT TO PROVIDE ADDITIONAL CAPITAL Dated as of August 11, 2004Agreement to Provide Additional Capital • August 16th, 2004 • Arrowhead Research Corp • Patent owners & lessors
This AMENDMENT NO. 1 TO AGREEMENT TO PROVIDE ADDITIONAL CAPITAL (this “Amendment”), amends the Agreement To Provide Additional Capital is made dated as of June 4, 2004, (the “Agreement”) by and between Arrowhead Research Corporation, a Delaware corporation (“Arrowhead”), and Insert Therapeutics, Inc., a California corporation (the “Company”). Capitalized terms not otherwise defined in this Amendment have the meanings ascribed to such terms in the Agreement. In consideration of the mutual covenants and agreements contained herein, the parties hereby agree amend and modify the Agreement as set forth below:
AGREEMENT TO PROVIDE ADDITIONAL CAPITALAgreement to Provide Additional Capital • August 16th, 2004 • Arrowhead Research Corp • Patent owners & lessors • California
THIS AGREEMENT TO PROVIDE ADDITIONAL CAPITAL (this “Agreement”) is made and entered into as of April 20, 2004, by and between Arrowhead Research Corporation, a Delaware corporation (“Arrowhead”), and Aonexx Technologies, Inc., a California corporation (the “Company”).
